Lyngbakken, Magnus Nakrem
Berdal, Jan-Erik
Eskesen, Arne
Kvale, Dag
Olsen, Inge Christoffer
Rangberg, Anbjørg
Jonassen, Christine Monceyron
Omland, Torbjørn
Røsjø, Helge
Dalgard, Olav
Article History
Received: 9 May 2020
Accepted: 14 May 2020
First Online: 5 June 2020
Ethics approval and consent to participate
: The study protocol was approved by the Regional Committees for Medical Research Ethics - South East Norway (REC 121446) on March 23, 2020, and the Norwegian Medicines Agency on March 18, 2020. The study is performed in accordance with the Declaration of Helsinki and Good Clinical Practice guidelines of the International Conference on Harmonization. All study participants will provide written informed consent before study inclusion.
: Not applicable.
: The authors declare that they have no competing interests.